Shopping Cart
- Remove All
- Your shopping cart is currently empty
Edrecolomab (Panorex), a murine monoclonal antibody targeting the 17-1A cell-surface glycoprotein on epithelial tissues and various carcinomas, exhibits anti-tumor properties and is utilized in colorectal carcinoma research [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | Edrecolomab (Panorex), a murine monoclonal antibody targeting the 17-1A cell-surface glycoprotein on epithelial tissues and various carcinomas, exhibits anti-tumor properties and is utilized in colorectal carcinoma research [1] [2]. |
In vitro | Edrecolomab, at concentrations ranging from 0 to 100 μg/mL over a 20-hour duration, exhibits moderate antibody-dependent cellular cytotoxicity (ADCC) [1]. |
In vivo | Edrecolomab administered intravenously at a dosage of 30 μg on days 1, 4, and 7 post-tumor-cell inoculation effectively suppresses tumor development in the HT-29 nude mouse model [1]. |
Alias | Panorex, CO17-1A |
Cas No. | 156586-89-9 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.